{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:48:37Z","timestamp":1772772517751,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ghir.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T19:31:49Z","timestamp":1438198309000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial"],"prefix":"10.1016","volume":"25","author":[{"given":"Alin","family":"Andries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 Klinkby","family":"St\u00f8ving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2015.07.006_bb0005","first-page":"79","article-title":"The role of the endocannabinoid system in the regulation of energy expenditure, best practice & research","volume":"23","author":"Cavuoto","year":"2009","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"J. Palliat. Care"},{"key":"10.1016\/j.ghir.2015.07.006_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ghir.2015.07.006_bb0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ghir.2015.07.006_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"Int. J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.ghir.2015.07.006_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40519-014-0132-5","article-title":"Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial","volume":"20","author":"Andries","year":"2014","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.ghir.2015.07.006_bb0035","first-page":"2056","article-title":"Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis","volume":"84","author":"Stoving","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0040","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1210\/jc.2006-1926","article-title":"Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa","volume":"92","author":"Stoving","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000124961","article-title":"Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat","volume":"48","author":"Rettori","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ghir.2015.07.006_bb0050","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.mce.2008.01.021","article-title":"Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio","volume":"286","author":"Migliarini","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2015.07.006_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.taap.2005.12.019","article-title":"Estrogenic effects of marijuana smoke condensate and cannabinoid compounds","volume":"214","author":"Lee","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ghir.2015.07.006_bb0060","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1210\/jc.2011-1222","article-title":"Endocrine dysregulation in anorexia nervosa update","volume":"96","author":"Miller","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2015.07.006_bb0070","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2015.07.006_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/00952990.2011.600398","article-title":"CB1 \u2014 cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men","volume":"38","author":"Goodwin","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.ghir.2015.07.006_bb0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2015.07.006_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/eat.20875","article-title":"Critical appraisal of the provisional DSM-5 criteria for anorexia nervosa and an alternative proposal","volume":"44","author":"Hebebrand","year":"2011","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.ghir.2015.07.006_bb0090","first-page":"791","article-title":"Leptin in anorexia nervosa","volume":"83","author":"Eckert","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2015.07.006_bb0100","first-page":"3861","article-title":"Serum leptin levels in women with anorexia nervosa","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0105","first-page":"3579","article-title":"Cerebrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans","volume":"84","author":"Hagan","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2011.11.001","article-title":"A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men","volume":"1431","author":"Riggs","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ghir.2015.07.006_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2265.2003.01702.x","article-title":"Hyperadiponectinaemia in anorexia nervosa","volume":"58","author":"Delporte","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.ghir.2015.07.006_bb0120","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/eat.22166","article-title":"Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration","volume":"46","author":"Terra","year":"2013","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.ghir.2015.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1210\/jc.2003-031260","article-title":"Adiponectin in anorexia nervosa and bulimia nervosa","volume":"89","author":"Tagami","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2003-42655","article-title":"Plasma adiponectin levels in women with anorexia nervosa","volume":"35","author":"Iwahashi","year":"2003","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2015.07.006_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tem.2006.11.006","article-title":"Endocannabinoids and the control of energy balance","volume":"18","author":"Matias","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2006-925401","article-title":"Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin","volume":"38","author":"Perwitz","year":"2006","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2015.07.006_bb0145","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2015.07.006_bb0150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ijo.2012.123","article-title":"Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity","volume":"37","author":"Ge","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ghir.2015.07.006_bb0155","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0160","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/jc.2013-3060","article-title":"Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays","volume":"99","author":"Friedrich","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","article-title":"Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays","volume":"57","author":"Clemmons","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2015.07.006_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ghir.2009.02.002","article-title":"The first international standard for insulin-like growth factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study","volume":"19","author":"Burns","year":"2009","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2015.07.006_bb0175","first-page":"E1149","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum, American journal of physiology","volume":"284","author":"Chen","year":"2003","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.07.006_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2369-14-80","article-title":"Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study","volume":"14","author":"Reinhard","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ghir.2015.07.006_bb0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ajh.2009.244","article-title":"Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study","volume":"23","author":"Asferg","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ghir.2015.07.006_bb0190","series-title":"Handbook of Statistical Analyses Using Stata","author":"Everitt","year":"2006"},{"key":"10.1016\/j.ghir.2015.07.006_bb0195","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1210\/jc.2004-0723","article-title":"Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism","volume":"89","author":"Misra","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:49:07Z","timestamp":1761086947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637415300174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1096637415300174"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2015.07.006","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}